Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration

dc.contributor.authorCarola, Giulia
dc.contributor.authorMalagarriga, Daniel
dc.contributor.authorCalatayud Aristoy, Carles
dc.contributor.authorPons-Espinal, Meritxell
dc.contributor.authorBlasco Agell, Lucas
dc.contributor.authorRichaud-Patin, Yvonne
dc.contributor.authorFernandez-Carasa, Irene
dc.contributor.authorBaruffi, Valentina
dc.contributor.authorBeltramone, Silvia
dc.contributor.authorMolina, Elsa
dc.contributor.authorDell’Era, Patrizia
dc.contributor.authorToledo Aral, Juan J.
dc.contributor.authorTolosa, Eduardo
dc.contributor.authorMuotri, Alysson R.
dc.contributor.authorGarcia Ojalvo, Jordi
dc.contributor.authorSoriano i Fradera, Jordi
dc.contributor.authorRaya Chamorro, Ángel
dc.contributor.authorConsiglio, Antonella
dc.date.accessioned2021-07-19T08:21:12Z
dc.date.available2021-07-19T08:21:12Z
dc.date.issued2021-07-02
dc.date.updated2021-07-16T07:19:47Z
dc.description.abstractA deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients' networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec707718
dc.identifier.idgrec707718
dc.identifier.issn2373-8057
dc.identifier.pmid34215735
dc.identifier.urihttps://hdl.handle.net/2445/179150
dc.language.isoeng
dc.publisherSpringer
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41531-021-00198-3
dc.relation.ispartofnpj Parkinson's Disease, 2021, vol. 7, num. 55
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/713140/EU//MESO_BRAIN
dc.relation.urihttps://doi.org/10.1038/s41531-021-00198-3
dc.rightscc by (c) Carola, Giulia et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationMalaltia de Parkinson
dc.subject.classificationMutació (Biologia)
dc.subject.classificationEnginyeria genètica
dc.subject.otherParkinson's disease
dc.subject.otherMutation (Biology)
dc.subject.otherGenetic engineering
dc.titleParkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s41531-021-00198-3.pdf
Mida:
7.85 MB
Format:
Adobe Portable Document Format